Biogen | BIIB - Ebit

Stock Price
179.03
Daily Change
-0.86 -0.48%
Monthly
1.73%
Yearly
24.39%
Q1 Forecast
174.35

Biogen reported $659.6M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Amgen USD 4.43B 2.17B Sep/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
Merck USD 7.56B 1.19B Sep/2025
Moderna USD -260M 557M Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.57B 1.97B Sep/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025